Endovascular brachytherapy and restenosis following lower limb angioplasty: Systematic review and meta-analysis of randomized clinical trials

Forbes, 2010, Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis, J Vasc Surg, 51, 43S, 10.1016/j.jvs.2010.01.076 Capek, 1991, Femoropopliteal angioplasty: factors influencing long-term success, Circulation, 83, I70 Shammas, 2009, Restenosis after lower extremity interventions: current status and future directions, J Endovasc Ther, 16, I170, 10.1583/08-2564.1 Schillinger, 2005, Restenosis after percutaneous angioplasty: the role of vascular inflammation, Vasc Health Risk Manag, 1, 73, 10.2147/vhrm.1.1.73.58932 Condado, 1997, Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans, Circulation, 96, 727, 10.1161/01.CIR.96.3.727 King, 1998, Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT), Circulation, 97, 2025, 10.1161/01.CIR.97.20.2025 Hagenaars, 2002, Gamma radiation induces positive vascular remodeling after balloon angioplasty: a prospective, randomized intravascular ultrasound scan study, J Vasc Surg, 36, 318, 10.1067/mva.2002.124373 van Tongeren, 2005, Endovascular brachytherapy for the prevention of restenosis after femoropopliteal angioplasty. Results of the VARA Trial, J Cardiovasc Surg (Torino), 46, 437 Krueger, 2002, Endovascular gamma irradiation of femoropopliteal de novo stenoses immediately after PTA: interim results of prospective randomized controlled trial, Radiology, 224, 519, 10.1148/radiol.2242010882 Krueger, 2004, De novo femoropopliteal stenoses: endovascular gamma irradiation following angioplasty–angiographic and clinical follow-up in a prospective randomized controlled trial, Radiology, 231, 546, 10.1148/radiol.2312030421 Minar, 2000, Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: results of a prospective randomized study, Circulation, 102, 2694, 10.1161/01.CIR.102.22.2694 Pokrajac, 2000, Intraarterial (192)Ir high-dose-rate brachytherapy for prophylaxis of restenosis after femoropopliteal percutaneous transluminal angioplasty: the prospective randomized Vienna-2-trial radiotherapy parameters and risk factors analysis, Int J Radiat Oncol Biol Phys, 48, 923, 10.1016/S0360-3016(00)00716-1 Wolfram, 2006, Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: five-year follow-up – prospective randomized study, Radiology, 240, 878, 10.1148/radiol.2403050883 Diehm, 2005, Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time, J Endovasc Ther, 12, 723, 10.1583/05-1583MR.1 Zehnder, 2003, Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions, J Endovasc Ther, 10, 304, 10.1177/152660280301000221 Pokrajac, 2005, Endovascular brachytherapy prevents restenosis after femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter study, Radiother Oncol, 74, 3, 10.1016/j.radonc.2004.08.015 Bonvini, 2003, Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries, J Am Coll Cardiol, 41, 409, 10.1016/S0735-1097(02)02684-0 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Ann Intern Med, 151, 264, 10.7326/0003-4819-151-4-200908180-00135 Jadad, 1996, Assessing the quality of reports of randomized clinical trials: is blinding necessary?, Control Clin Trials, 17, 1, 10.1016/0197-2456(95)00134-4 Der Simonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Wyttenbach, 2007, Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodeling of human femoropopilteal artery: 2 years follow-up by noninvasive magnetic resonance imaging, Eur J Vasc Endovasc Surg, 34, 416, 10.1016/j.ejvs.2007.05.017 Wyttenbach, 2004, Effects of percutaneous transluminal angioplasty and endovascular brachytherapy on vascular remodelling of human femoropopliteal artery by noninvasive magnetic resonance imaging, Circulation, 110, 1156, 10.1161/01.CIR.0000140672.70862.5B Waksman, 2004, An update on peripheral brachytherapy, Endovasc Today, 43 Serrano, 1997, Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty, J Am Coll Cardiol, 29, 1276, 10.1016/S0735-1097(97)00070-3 Belch, 1997, The white blood cell adhesion molecule E-selectin predicts restenosis in patients with intermittent claudication undergoing percutaneous transluminal angioplasty, Circulation, 95, 2027, 10.1161/01.CIR.95.8.2027 Schillinger, 2004, Endovascular brachytherapy: effect on acute inflammatory response after percutaneous femoropopliteal arterial interventions, Radiology, 230, 556, 10.1148/radiol.2302021690 Hopewell, 2007, Grey literature in meta-analyses of randomized trials of healthcare interventions, Cochrane Database Syst Rev, 2, MR000010